Address

OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States

Open map


Recent investment activity

KANDO id: 29979

Corporate information

Official name
OrbiMed Advisors Limited Liability Company
Registration country

Funding rounds

Investment preferences

Investment focus themes
Top investment portfolio themes

Actual initial investment stage
N/A (2)
Venture (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 114
Profile Country Date Funding
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. Series A Initial investment
Armo BioSciences Inc Late-stage immuno-oncology company. Series C-1 Follow-on investment
Nutrinia Ltd Developer of an oral formulation of insulin for intestinal malabsorption in preterm newborns and SBS in infants. Series D Follow-on investment
Tricida Inc Series C Follow-on investment
Tricida Inc Series B Follow-on investment led the round
Tricida Inc Series A led the round
Natera Inc Biotechnology company providing preconception and prenatal genetic testing services. Venture Initial investment led the round
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series F
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways Series A
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. Series D
Complete Genomics Inc Series E
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series E Follow-on investment
Selecta Biosciences Inc A biotechnology company developing a new class of synthetic nanoparticle vaccines. Series C
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series D Follow-on investment
Adimab LLC Developer of a human antibody discovery platform in yeast. Series D
Complete Genomics Inc Series D
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. Series D
ARYx Therapeutics Inc N/A Initial investment
Biolex Therapeutics Inc Series D
Innovative Spinal Technologies Inc Spine technology company. Series C
Glaukos Corp Series D
InteKrin Therapeutics Inc Biopharmaceutical company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders.. Series C
Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. N/A
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series C Initial investment
Enobia Pharma Corp Series B

Past employees

Selected Products / Customers

Financials